Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Hartmann

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Blood Cancer Journal|March 24, 2023
Prognostic value of extracellular matrix gene mutations and expression in multiple myelomaMarietheres Evers, Martin Schreder, Thorsten Stühmer, et al.
Circulation. Genomic and Precision Medicine|October 19, 2021
Coronary Artery Disease Polygenic Risk Score Identifies Patients at Higher Risk for Recurrent Cardiovascular Events in the CANTOS TrialHuilei Xu, Claudia Hon, Sergio Kaiser, et al.
Hematological Oncology|November 16, 2021
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemiaErika Tissino, Eliana Pivetta, Alessandra Capuano, et al.
The Journal of Pathology|March 31, 2015
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocationOlaf Merkel, Frank Hamacher, Robert Griessl, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Identification and evaluation of novel acetolactate synthase inhibitors as antifungal agentsDaryl L Richie, Katherine V Thompson, Christian Studer, et al.
Cancers|January 11, 2025
A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug ResistanceEleni E Ladikou, Kim Sharp, Fabio A Simoes, et al.
American Journal of Human Genetics|September 2, 2023
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic backgroundCong Zhang, Konstantin Shestopaloff, Benjamin Hollis, et al.
European Journal of Immunology|August 13, 2004
Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient miceBruno Luckow, Joanne Joergensen, Silvia Chilla, et al.
Journal of Leukocyte Biology|December 10, 2021
Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiationAndrea Härzschel, Lixia Li, Peter W Krenn, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|March 24, 2023
Prognostic value of extracellular matrix gene mutations and expression in multiple myelomaMarietheres Evers, Martin Schreder, Thorsten Stühmer, et al.
Circulation. Genomic and Precision Medicine|October 19, 2021
Coronary Artery Disease Polygenic Risk Score Identifies Patients at Higher Risk for Recurrent Cardiovascular Events in the CANTOS TrialHuilei Xu, Claudia Hon, Sergio Kaiser, et al.
Hematological Oncology|November 16, 2021
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemiaErika Tissino, Eliana Pivetta, Alessandra Capuano, et al.
The Journal of Pathology|March 31, 2015
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocationOlaf Merkel, Frank Hamacher, Robert Griessl, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2013
Identification and evaluation of novel acetolactate synthase inhibitors as antifungal agentsDaryl L Richie, Katherine V Thompson, Christian Studer, et al.
Cancers|January 11, 2025
A Novel In Vitro Model of the Bone Marrow Microenvironment in Acute Myeloid Leukemia Identifies CD44 and Focal Adhesion Kinase as Therapeutic Targets to Reverse Cell Adhesion-Mediated Drug ResistanceEleni E Ladikou, Kim Sharp, Fabio A Simoes, et al.
American Journal of Human Genetics|September 2, 2023
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic backgroundCong Zhang, Konstantin Shestopaloff, Benjamin Hollis, et al.
European Journal of Immunology|August 13, 2004
Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient miceBruno Luckow, Joanne Joergensen, Silvia Chilla, et al.
Journal of Leukocyte Biology|December 10, 2021
Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiationAndrea Härzschel, Lixia Li, Peter W Krenn, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 21, 2023
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized studyBaltazar GomezMancilla, Matthew N Meriggioli, Angela Genge, et al.
Pageof 9